Vaccination with live attenuated simian immunodeficiency virus causes dynamic changes in intestinal CD4+CCR5+ T cells

Bo Li(National Institute for Biological Standards and Control), Neil Berry(National Institute for Biological Standards and Control), Claire Ham(National Institute for Biological Standards and Control), Deborah Ferguson(National Institute for Biological Standards and Control), Deborah Smith(National Institute for Biological Standards and Control), Joanna Hall(National Institute for Biological Standards and Control), Mark Page(National Institute for Biological Standards and Control), Ruby Quartey‐Papafio(National Institute for Biological Standards and Control), William Elsley(National Institute for Biological Standards and Control), Mark W. Robinson(National Institute for Biological Standards and Control), Neil Almond(National Institute for Biological Standards and Control), Richard Stebbings(National Institute for Biological Standards and Control)
Retrovirology
February 3, 2011
Cited by 7Open Access
Full Text

Abstract

BACKGROUND: Vaccination with live attenuated SIV can protect against detectable infection with wild-type virus. We have investigated whether target cell depletion contributes to the protection observed. Following vaccination with live attenuated SIV the frequency of intestinal CD4+CCR5+ T cells, an early target of wild-type SIV infection and destruction, was determined at days 3, 7, 10, 21 and 125 post inoculation. RESULTS: In naive controls, modest frequencies of intestinal CD4+CCR5+ T cells were predominantly found within the LPL TTrM-1 and IEL TTrM-2 subsets. At day 3, LPL and IEL CD4+CCR5+ TEM cells were dramatically increased whilst less differentiated subsets were greatly reduced, consistent with activation-induced maturation. CCR5 expression remained high at day 7, although there was a shift in subset balance from CD4+CCR5+ TEM to less differentiated TTrM-2 cells. This increase in intestinal CD4+CCR5+ T cells preceded the peak of SIV RNA plasma loads measured at day 10. Greater than 65.9% depletion of intestinal CD4+CCR5+ T cells followed at day 10, but overall CD4+ T cell homeostasis was maintained by increased CD4+CCR5- T cells. At days 21 and 125, high numbers of intestinal CD4+CCR5- naive TN cells were detected concurrent with greatly increased CD4+CCR5+ LPL TTrM-2 and IEL TEM cells at day 125, yet SIV RNA plasma loads remained low. CONCLUSIONS: This increase in intestinal CD4+CCR5+ T cells, following vaccination with live attenuated SIV, does not correlate with target cell depletion as a mechanism of protection. Instead, increased intestinal CD4+CCR5+ T cells may correlate with or contribute to the protection conferred by vaccination with live attenuated SIV.


Related Papers

No related papers found

Powered by citation graph analysis